Cargando…

Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report

BACKGROUND: Anti-aminoacyl-tRNA synthetase (ARS) antibody-positive patients present with a variety of symptoms, including interstitial lung disease (ILD), which is termed anti-synthetase syndrome (ASS). But it is rare that ASS-ILD is considered an immune-related adverse event after the use of immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Ippei, Shimizu, Tetsuo, Kusahana, Ryo, Nomoto, Masayuki, Fujiwara, Daishi, Nishizawa, Tsukasa, Hayashi, Kentaro, Nakagawa, Yoshiko, Gon, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165749/ https://www.ncbi.nlm.nih.gov/pubmed/37158856 http://dx.doi.org/10.1186/s12890-023-02446-z

Ejemplares similares

Retrospective Analysis of the Incidence of Drug-Induced Interstitial Lung Disease by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Survival in Patients Aged 75 Years or Older with Lung Cancer
por: Ishibashi, Masayuki, et al.
Publicado: (2023)

Interstitial Lung Disease in Anti-Synthetase Syndrome
por: Kourkouni, Evangelia, et al.
Publicado: (2019)

Successful treatment of refractory brain metastases from ALK‐positive lung cancer with lorlatinib
por: Nakagawa, Yoshiko, et al.
Publicado: (2022)

Anti-synthetase syndrome presenting with interstitial lung disease
por: Athanassiou, Panagiotis, et al.
Publicado: (2017)

A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer
por: Shimizu, Tetsuo, et al.
Publicado: (2019)

Comprehensive genetic analysis of histological components of combined small cell carcinoma
por: Iida, Yuko, et al.
Publicado: (2022)

Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies
por: Jiang, Minna, et al.
Publicado: (2021)

The Diagnosis of Exogenous Lipoid Pneumonia Caused by the Silent Aspiration of Vegetable Oil Using a Lipidomic Analysis
por: Shimizu, Tetsuo, et al.
Publicado: (2019)

Anti-Synthetase Syndrome-Related Interstitial Lung Disease With Anti-PL-12 Antibodies
por: Elferjani, Belqis, et al.
Publicado: (2021)

Successful baricitinib treatment of refractory anti‐synthetase syndrome associated with interstitial lung disease
por: Sugino, Keishi, et al.
Publicado: (2023)

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report
por: Yamakawa, Hideaki, et al.
Publicado: (2019)

Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome
por: Ge, Yongpeng, et al.
Publicado: (2020)

A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach
por: Sawal, Naina, et al.
Publicado: (2021)

Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser‐assisted microdissection: A case report
por: Iida, Yuko, et al.
Publicado: (2021)

Small‐cell lung cancer from the peripheral lung is frequently accompanied by emphysema and interstitial lung disease in the background
por: Ikematsu, Yuki, et al.
Publicado: (2022)

Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China
por: Zhan, Xi, et al.
Publicado: (2021)

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Anti‐synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition
por: Bell, Peter T., et al.
Publicado: (2023)

Successful treatment with atezolizumab combination chemotherapy in a patient with high‐grade fetal adenocarcinoma of the lung: A case report
por: Fujimoto, Kana, et al.
Publicado: (2022)

Use of Atezolizumab for Bladder and Non–Small Cell Lung Cancers
por: Moore, Kayla Faith
Publicado: (2017)

Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma
por: Yamaguchi, Yoshitaka, et al.
Publicado: (2021)

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
por: Zhu, Lili, et al.
Publicado: (2022)

Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment
por: Nakashima, Kei, et al.
Publicado: (2020)

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis
por: Ikeda, Satoshi, et al.
Publicado: (2020)

Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
por: Seto, Takashi, et al.
Publicado: (2022)

Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
por: Sodsri, Tulaton, et al.
Publicado: (2023)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Atezolizumab-Induced Autoimmune Diabetes in a Patient With Metastatic Lung Cancer
por: Sothornwit, Jin, et al.
Publicado: (2019)

Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report
por: Yamaguchi, Yoshitaka, et al.
Publicado: (2020)

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
por: Kato, Motoyasu, et al.
Publicado: (2014)

Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
por: Sato, Shintaro, et al.
Publicado: (2020)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

Successful Re-administration of Atezolizumab for a Non-small-cell Lung Cancer Patient after Cardiac Tamponade Development as a Manifestation of Pseudo-progression Induced by Combination Treatment with Atezolizumab and Cytotoxic Chemotherapy
por: Nakashima, Koki, et al.
Publicado: (2021)

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
por: Kanemura, Hiroaki, et al.
Publicado: (2020)

Outcomes of Video-Assisted Thoracic Surgical Lung Biopsy for Interstitial Lung Diseases
por: Nagano, Masaaki, et al.
Publicado: (2021)

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients
por: Katayama, Yuki, et al.
Publicado: (2020)

Immune‐related aseptic meningitis diagnosed by Cube FLAIR on enhanced magnetic resonance imaging for a lung cancer patient administered atezolizumab: A case report
por: Kuroda, Ryo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rfqa7n0rj265qokhedne6t67vo